We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current LTP market cap is 42.24M. The company's latest EPS is AUD -0.0988 and P/E is -6.07.
| Year End 30 June 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 9k | 0 | 49k |
| Operating Income | -29k | -1.02M | -1.44M | -6.94M |
| Net Income | -41k | -1.03M | -1.46M | -6.95M |
| Year End 30 June 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 423k | 2.25M | 2.09M | 3.37M |
| Total Liabilities | 464k | 476k | 22k | 428k |
| Total Equity | -41k | 1.77M | 2.07M | 2.94M |
| Year End 30 June 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -29k | -568k | -1.54M | -5.09M |
| Investing | N/A | N/A | -2k | -2k |
| Financing | 178k | 2.34M | 1.38M | 6.5M |
| Market Cap | 42.24M |
| Price to Earnings Ratio | -6.07 |
| Price to Sales Ratio | 857.14 |
| Price to Cash Ratio | 13.61 |
| Price to Book Ratio | 14.36 |
| Dividend Yield | - |
| Shares Outstanding | 70.41M |
| Average Volume (1 week) | 649.84k |
| Average Volume (1 Month) | 568.09k |
| 52 Week Change | 87.50% |
| 52 Week High | 2.15 |
| 52 Week Low | 0.235 |
| Spread (Intraday) | 0.04 (6.25%) |
| Company Name | LTR Pharma Ltd |
| Address |
9/204 alice street brisbane, queensland 4000 |
| Website | https://www.ltrpharma.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
